Anne-Ruxandra Carvunis

Dr. Anne-Ruxandra Carvunis

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2014 in Cell
Verified
Journal Article
Closed access
TRThomas Rolland
Thomas Rolland
MTMurat Taşan
Murat Taşan
BCBenoit Charloteaux
Benoit Charloteaux
SPSamuel J. Pevzner
Samuel J. Pevzner
QZQuan Zhong
Quan Zhong
MVMarc Vidal
Marc Vidal

29 July 2011 in Science
Verified
Journal Article
Closed access
PDF file
Shahid MukhtarShahid Mukhtar
Shahid Mukhtar
ACAnne-Ruxandra Carvunis
Anne-Ruxandra Carvunis
MDMatija Dreze
Matija Dreze
PEPetra Epple
Petra Epple
JSJens Steinbrenner
Jens Steinbrenner
JDJeffery L. Dangl
Jeffery L. Dangl
An analysis of protein-protein interactions in Arabidopsis identifies the plant interactome.

24 June 2012 in Nature
Verified
Journal Article
Open access
PDF file
ACAnne-Ruxandra Carvunis
Anne-Ruxandra Carvunis
TRThomas Rolland
Thomas Rolland
IWIlan Wapinski
Ilan Wapinski
MCMichael A. Calderwood
Michael A. Calderwood
MYMuhammed A. Yildirim
Muhammed A. Yildirim
MVMarc Vidal
Marc Vidal
Novel protein-coding genes can arise either from pre-existing genes or de novo; here it is shown that functional genes emerge de novo through transitory proto-genes generated by widespread translational activity in non-genic sequences. De novo gene birth has occurred in many lineages during evolution, but how functional protein-coding genes emerge in non-functional sequences — rather than through gene rearrangement — remains unresolved. These authors observe in the yeast Saccharomyces cerevisiae that hundreds of species-specific non-genic transcripts are differentially regulated upon stress. These previously overlooked translation events seem to act as a reservoir of adaptive potential, in the form of open reading frames that occupy an evolutionary continuum ranging from non-genic sequences to genes. On the basis of their genome-wide observations, the authors suggest that de novo gene birth from the proto-gene reservoir may be more prevalent than sporadic gene duplication. Novel protein-coding genes can arise either through re-organization of pre-existing genes or de novo1,2. Processes involving re-organization of pre-existing genes, notably after gene duplication, have been extensively described1,2. In contrast, de novo gene birth remains poorly understood, mainly because translation of sequences devoid of genes, or ‘non-genic’ sequences, is expected to produce insignificant polypeptides rather than proteins with specific biological functions1,3,4,5,6. Here we formalize an evolutionary model according to which functional genes evolve de novo through transitory proto-genes4 generated by widespread translational activity in non-genic sequences. Testing this model at the genome scale in Saccharomyces cerevisiae, we detect translation of hundreds of short species-specific open reading frames (ORFs) located in non-genic sequences. These translation events seem to provide adaptive potential7, as suggested by their differential regulation upon stress and by signatures of retention by natural selection. In line with our model, we establish that S. cerevisiae ORFs can be placed within an evolutionary continuum ranging from non-genic sequences to genes. We identify ∼1,900 candidate proto-genes among S. cerevisiae ORFs and find that de novo gene birth from such a reservoir may be more prevalent than sporadic gene duplication. Our work illustrates that evolution exploits seemingly dispensable sequences to generate adaptive functional innovation.

18 September 2013 in Nature Reviews Genetics
Verified
Journal Article
Closed access
PDF file
KMKoyel Mitra
Koyel Mitra
ACAnne-Ruxandra Carvunis
Anne-Ruxandra Carvunis
SRSanath Kumar Ramesh
Sanath Kumar Ramesh
TITrey Ideker
Trey Ideker

18 July 2012 in Nature
Verified
Journal Article
Open access
PDF file
OROrit Rozenblatt-Rosen
Orit Rozenblatt-Rosen
RDRahul C. Deo
Rahul C. Deo
MPMegha Padi
Megha Padi
GAGuillaume Adelmant
Guillaume Adelmant
MCMichael A. Calderwood
Michael A. Calderwood
MVMarc Vidal
Marc Vidal
Combining analysis of host proteome and transcriptome perturbations induced by tumour virus proteins with ongoing genome-wide studies of cancer facilitates the prioritization of cancer genes. This systematic search for host targets of tumour viruses, using proteome and transcriptome analyses of viral proteins from mammalian DNA viruses with transforming or tumorigenic properties, provides an extensive catalogue of changes in genetic and protein expression that can be screened against genome-wide studies of cancer. The study focuses on human papillomavirus, Epstein–Barr virus, adenovirus and polyomavirus. The resulting list of transforming viral protein targets identifies causal genes within both somatic and Mendelian cancer-associated loci. Genotypic differences greatly influence susceptibility and resistance to disease. Understanding genotype–phenotype relationships requires that phenotypes be viewed as manifestations of network properties, rather than simply as the result of individual genomic variations1. Genome sequencing efforts have identified numerous germline mutations, and large numbers of somatic genomic alterations, associated with a predisposition to cancer2. However, it remains difficult to distinguish background, or ‘passenger’, cancer mutations from causal, or ‘driver’, mutations in these data sets. Human viruses intrinsically depend on their host cell during the course of infection and can elicit pathological phenotypes similar to those arising from mutations3. Here we test the hypothesis that genomic variations and tumour viruses may cause cancer through related mechanisms, by systematically examining host interactome and transcriptome network perturbations caused by DNA tumour virus proteins. The resulting integrated viral perturbation data reflects rewiring of the host cell networks, and highlights pathways, such as Notch signalling and apoptosis, that go awry in cancer. We show that systematic analyses of host targets of viral proteins can identify cancer genes with a success rate on a par with their identification through functional genomics and large-scale cataloguing of tumour mutations. Together, these complementary approaches increase the specificity of cancer gene identification. Combining systems-level studies of pathogen-encoded gene products with genomic approaches will facilitate the prioritization of cancer-causing driver genes to advance the understanding of the genetic basis of human cancer.

23 May 2019 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
SOStephen Branden Van Oss
Stephen Branden Van Oss
ACAnne-Ruxandra Carvunis
Anne-Ruxandra Carvunis
De novo gene birth is the process by which new genes evolve from DNA sequences that were ancestrally non-genic. De novo genes represent a subset of novel genes, and may be proteincoding or instead act as RNA genes [1]. The processes that govern de novo gene birth (Fig 1A) are not well understood, though several models exist that describe possible mechanisms by which de novo gene birth may occur. Although de novo gene birth may have occurred at any point in an organism's evolutionary history, ancient de novo gene birth events are difficult to detect. Most studies of de novo genes to date have thus focused on young genes, typically taxonomically-restricted genes (TRGs) that are present in a single species or lineage, including socalled orphan genes, defined as genes that lack any identifiable homolog. It is important to note, however, that not all orphan genes arise de novo, and instead may emerge through fairly well-characterized mechanisms such as gene duplication (including retroposition) or horizontal gene transfer followed by sequence divergence, or by gene fission/fusion [2, 3] (Fig 2) Though de novo gene birth was once viewed as a highly unlikely occurrence [4], there are now several unequivocal examples of the phenomenon that have been described. It furthermore has been advanced that de novo gene birth plays a major role in the generation of evolutionary innovation [5, 6].